

[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
[ Wed, Jan 03rd 2024
] - WOPRAI
Uy Ear Upgraded (ARQT) to Strong Buy and Increased Target to $8 on, Jan 3rd, 2024
Uy Ear of Mizuho, Upgraded "Arcutis Biotherapeutics, Inc." (ARQT) to Strong Buy and Increased Target from $4 to $8 on, Jan 3rd, 2024.
Uy has made no other calls on ARQT in the last 4 months.
There are 4 other peers that have a rating on ARQT. Out of the 4 peers that are also analyzing ARQT, 2 agree with Uy's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Sean Kim of "JonesTrading" Downgraded from Strong Buy to Hold on, Wednesday, November 8th, 2023
- Jonathan Block of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $6 on, Friday, October 13th, 2023
These are the ratings of the 2 analyists that currently disagree with Uy
- Nigel Dally of "Morgan Stanley" Maintained at Buy with Decreased Target to $10 on, Monday, November 13th, 2023
- Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $8 on, Monday, November 6th, 2023
Contributing Sources